HugoScore hugoscore.org

Mental health AI

Ash

Ash offers patient-chosen mental health conversations. Published conditions describe opt-in improvement use, whose implementation was not tested. Its qualified agency finding does not establish clinical effectiveness or control over every therapeutic goal.

Document-based draft Read full report Open directory

Checklist assessment dated October 30, 2026. Independent confirmation is incomplete. Hugo has not personally verified this service.

Leans expands8 of 12 agency checks metDocument-based draft. Independent confirmation incomplete; not product-tested.How categories work

Agency checklist · October 30, 2026

Leans expands 8 of 12 yes

Document-based draft. Independent confirmation is incomplete. Hugo has not personally verified this service.

Assessed function: Slingshot AI's adult consumer emotional-support app Ash, with self-directed or AI-guided conversations. A vendor-controlled self-help service, not professional therapy or crisis response.

A no can mean missing documentation or institution-dependent control; it does not by itself establish harmful behavior. These categories are not clinical safety or product-quality ratings.

  • Public documents do not establish actual product behavior.
  • The independent review screened rules and selected evidence; it did not replicate all twelve answers for this tool.
See all twelve answers and their evidence
QuestionAnswerEvidence / reviewSource and reasoning
1. Told it is AIYesdocumented
Not independently replicated
conversational techniques powered by an artificial intelligence powered technology Source

The home page also says 'AI designed for mental health'. The EULA says outputs are 'susceptible to inaccuracies... including hallucinations'.

2. Operator and model maker namedYesdocumented
Not independently replicated
Slingshot built Ash, the first foundation model for psychology, on the cloud provider's infrastructure Source

Slingshot AI, Inc. is the operator. Slingshot says it built its own model, with Nebius as infrastructure. The base model lineage is not disclosed.

3. Patient chooses to use itYesdocumented
Not independently replicated
launched as a free iOS and Android download in July 2025 Source

The user downloads the app and starts. Subscription terms apply for paid features.

4. Patient sets the taskYesdocumented
Not independently replicated
Come with your own agenda or let Ash guide the way. Source

The user can set the topic or choose AI-guided sessions. The AI-guided mode and the 'program' that Ash creates are Ash-directed, so a reviewer may weigh steering.

5. Patient can decline or stopYesdocumented
Not independently replicated
launched as a free iOS and Android download in July 2025 Source

Self-started tool per the Q3 source, no care depends on it.

6. Patient sees the AI outputYesdocumented
Not independently replicated
your conversation history is available to you at any time Source

Voice is not retained as a recording beyond transcription.

7. Patient can correct or challengeNonot-documented
Not independently replicated
Quotation not recorded; evidence repair pending. Source

The privacy policy lists correcting inaccurate personal information only 'depending on where you live'. No route to contest Ash output.

8. Patient can get a copyNonot-documented
Not independently replicated
Quotation not recorded; evidence repair pending. Source

The policy says access to or a copy of personal information may be available depending on where you live, via email. No general export is documented. The app shows conversation history, which is viewing, not a copy.

9. Patient can deleteYesdocumented
Not independently replicated
you may request deletion by selecting “delete my data” in the Platform and confirming the selection. Source

Deleting name and contact information requires deleting the account and emailing support.

10. Training or sale does not override patient choiceYesdocumented
Not independently replicated
We do not use your conversation transcripts to train or improve Ash, or make them available to our team Source

Opt-in only: the policy says 'unless you opt in to sharing them', and opted-in text is scrubbed of personal information. Opt-in data is also used for research with academic partners.

11. Patient can run it or take it elsewhereNonot-documented
Not independently replicated
Quotation not recorded; evidence repair pending. Source

Vendor-hosted only.

12. No advertising or data businessNodocumented
Not independently replicated
device and advertising identifiers, and analytics and attribution technologies Source

Conversation content is not shared with analytics or advertising partners, per the consumer health notice. But device and advertising identifiers and activity data go to analytics and attribution providers such as AppsFlyer, and the notice says Slingshot may 'use and share' de-identified data. Reviewer should confirm whether this counts as a data business.

Initial coding: Claude Sonnet helpers, compiled by Claude Opus 5.5 (Anthropic). Selective review and corrections: GPT-6 Astra (OpenAI). Editor: Hugo Campos. Acceptance of corrections is not product verification.

Checklist rules · Independent review and limitations · Later evidence follow-up

Earlier v1.3 assessment and control finding

Historical assessment under different rules. It does not set the current checklist zone.

MixedEarlier review, before the published method. Documents only.

Agency finding, before method v1.3

Mixed, access gains with unproven clinical claims

Legacy editorial placement, pre-method: 70

This profile has not yet been reviewed under the published method. Its finding and any number are editorial placements made before the method existed.

Evidence
Documentary review. Public sources only, no hands-on testing by HugoScore.
Review status
AI draft. No person has settled the findings.
The question we ask Who does Ash serve in this deployment?
Control Slingshot AI's adult consumer emotional-support app Ash, with self-directed or AI-guided conversations. A vendor-controlled self-help service, not professional therapy or crisis response.
Agency read Leans expands
Vendor
Slingshot AI, Inc.
Who it serves
Patient-directed consumer mental health chatbot, vendor-controlled and venture-funded, with contested clinical positioning
Primary User
Adults 18 and older seeking emotional support, self-reflection, and everyday mental health help
Control Model
Vendor-hosted public service. Controls and downstream processors depend on the assessed deployment.
Patient Impact
Reflection and pattern suggestions may expand understanding, but claims that an AI has found a personal pattern need inspectable evidence and opportunities to disagree. Friendly language and engagement are insufficient proof.
Profile Status
Document-based draft
Last assessed
Oct 30, 2026
Earlier review confidence
Medium for updated rights and scope (AI-assisted draft)
Earlier review model
OpenAI Codex / GPT-6
Earlier human review record
Hugo Campos authorized publication of these AI-assisted draft reassessments on September 8, 2026. This does not claim comprehensive human verification of every finding.

Earlier evidence and assessment

The sections below preserve the earlier review. Its classifications and provenance are historical; the checklist above gives the current draft classification.

Earlier finding · Legacy editorial placement, pre-method: 70

Method v1.3. The control line is evidence for how the agency finding arose, not a quality score. Legacy editorial placement, pre-method: 70. Not comparable with v1.3 positions.

Mixed, access gains with unproven clinical claims

Ash offers patient-chosen mental health conversations. Published conditions describe opt-in improvement use, whose implementation was not tested. Its qualified agency finding does not establish clinical effectiveness or control over every therapeutic goal.

Patient agency

How this tool changes agency

Expands agency when

Reflection and pattern suggestions may expand understanding, but claims that an AI has found a personal pattern need inspectable evidence and opportunities to disagree. Friendly language and engagement are insufficient proof.

Limits agency when

Actual consent defaults, editing or rejecting stored insights, generated-output portability, pricing by region, and independent evidence beyond the bounded index review.

Patient agency assessment

Who sets and changes the goal?

Patient authority

Users can set the agenda and decline training participation as documented. No direct mechanism for overriding persistent psychological characterizations was established.

What can the patient understand, question, or do?

Critical capacity

Reflection and pattern suggestions may expand understanding, but claims that an AI has found a personal pattern need inspectable evidence and opportunities to disagree. Friendly language and engagement are insufficient proof.

Can the patient evaluate the conditions of use?

Informed control

The revised policy and EULA are materially clearer about data use. Generated-content reuse and the basis of personal insights remain less clear than input ownership.

Text findings

Conditions of use

Published controls and their limits

The revised policy and EULA are materially clearer about data use. Generated-content reuse and the basis of personal insights remain less clear than input ownership.

What remains unknown?

Not tested or not established

Actual consent defaults, editing or rejecting stored insights, generated-output portability, pricing by region, and independent evidence beyond the bounded index review.

Who evaluated this?

AI-assisted public-source draft

Vendor statements describe published conditions, not independently verified behavior. No clinical, security, accessibility, or legal validation is claimed. Earlier evidence remains dated in the report and history.

Sources checked

Source-specific findings and retrieval limitations are recorded in the full report.

Earlier review provenance

Criteria

CAIHL-derived HugoScore framework and September 7 qualitative review priorities. Draft v1.2 numerical anchors remain unadopted.

Reviewer

AI-assisted public-source reassessment prepared in OpenAI Codex.

AI / model

OpenAI Codex / GPT-6

Human review

Hugo Campos authorized publication of these AI-assisted draft reassessments on September 8, 2026. This does not claim comprehensive human verification of every finding.

Review date

2026-09-08

Limitations

Actual consent defaults, editing or rejecting stored insights, generated-output portability, pricing by region, and independent evidence beyond the bounded index review. No live product use, patient-data upload, account creation, code audit, clinical evaluation, or independent implementation validation.

Earlier review method

Focused public-source reassessment using CAIHL: patient authority, critical capacity, and informed control. Existing evidence plus one focused primary-source pass and at most one targeted follow-up. No live product testing. Numerical scores remain provisional editorial placements, not a new calculation.

Document-based draft · Medium for updated rights and scope (AI-assisted draft)